drugset / Trial / NCT02057198
Impact of Oral Antibiotic Treatment on C. Difficile
RandomizedParallel-groupOpen-labelTreatment
Summary
The overall aim is to characterize and to compare the extent and quantity of C. difficile stool shedding, perianal colonization and environmental contamination in patients who received oral fidaxomicin, oral metronidazole, or oral vancomycin. This is a prospective, randomized, microbiologic and molecular, study of environmental contamination from patients with proven C. difficile associated diarrhea (CDAD).
Timeline
- Start
- 2014-06-10
- Primary completion
- 2017-06-27
- Completion
- 2017-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fidaxomicin | Other / unclassified | 200 mg | Oral |
| Comparator | Metronidazole | Small molecule | 500 mg | Oral |
| Comparator | Vancomycin | Other / unclassified | 125 mg | Oral |